Doctors at Cardiovascular Specialists of Southwest Louisiana successfully implanted the first Watchman® left atrial appendage occlusion device, an alternative to anti-coagulation (blood thinners) in patients with atrial-fibrillation.
Dr. Thomas Mulhearn of Cardiovascular Specialists of Louisiana presents a complex PCI case in the setting of severe LV dysfunction. The 49 year old male patient presented to a satellite office with chest pain. He had poorly controlled type II diabetes, hypertension, hyperlipidemia, and he was a smoker. An angiogram showed a normal left main, but significant LAD disease, a proximal lesion, an occluded vessel in the mid-segment, along with a circumflex that was non-dominant with high grade...
The doctors at Cardiovascular Specialists of Southwest Louisiana have performed almost every treatment or procedure in cardiology available anywhere in the world—except for heart transplantation—right here in Lake Charles, Louisiana. Being a part of many medical firsts in our region—heart catheterizations, dual-chamber pacemakers, and implantable defibrillators—Michael C. Turner, M.D. is no stranger to breaking new ground for cardiac patients in Southwest Louisiana.
Dr. Michael Turner MD, FACC, FSCCT, preventive cardiology specialist with Cardiovascular Specialists, has been appointed co -editor for the new CT section of the international online journal Echocardiography, the official publication of the Society of Cardiovascular Ultrasound.
An article submitted by Dr. Michael Turner MD, FACC, FSCCT, preventive cardiology specialist with Cardiovascular Specialists in Lake Charles was published last month in the medical journal Echocardiography.
Patients can now get the same protection from sudden cardiac arrest as they would get with a defibrillator but through a less invasive procedure that does not touch their heart and blood vessels, thanks to the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD).
Cardiovascular Specialists of Southwest Louisiana was selected as an investigative site for the PROMISE Trial, a study of the effectiveness of tests to detect coronary artery disease. Michael C. Turner, M.D., is principal investigator and Thomas J. Mulhearn IV, M.D., is co-investigator.
Dr. Corey G. Foster, Cardiologist with Cardiovascular Specialists, an affiliate of Imperial Health, has been awarded Board Certification in cardiovascular disease by the American Board of Internal Medicine.
Brett Goodwin, MD, cardiologist, is the newest member of the Imperial Health Medical Staff. Originally from Southwest Louisiana, Dr. Goodwin is board certified in Internal Medicine, Cardiovascular Disease, and Adult Echocardiography.